Variability in prescription opioid intake and reinforcement amongst 129 substrains.

TitleVariability in prescription opioid intake and reinforcement amongst 129 substrains.
Publication TypeJournal Article
Year of Publication2017
AuthorsJimenez SM, Healy AF, Coelho MA, Brown CN, Kippin TE, Szumlinski KK
JournalGenes Brain Behav
Volume16
Issue7
Pagination709-724
Date Published2017 09
ISSN1601-183X
KeywordsAnalgesics, Opioid, Animals, Fentanyl, Genetic Variation, Heroin, Male, Mice, Opioid-Related Disorders, Oxycodone, Reinforcement (Psychology), Substance Withdrawal Syndrome
Abstract

Opioid abuse in the United States has reached epidemic proportions, with treatment admissions and deaths associated with prescription opioid abuse quadrupling over the past 10 years. Although genetics are theorized to contribute substantially to inter-individual variability in the development, severity and treatment outcomes of opioid abuse/addiction, little direct preclinical study has focused on the behavioral genetics of prescription opioid reinforcement and drug-taking. Herein, we employed different 129 substrains of mice currently available from The Jackson Laboratory (129S1/SvlmJ, 129X1/SvJ, 129S4/SvJaeJ and 129P3/J) as a model system of genetic variation and assayed mice for oral opioid intake and reinforcement, as well as behavioral and somatic signs of dependence. All substrains exhibited a dose-dependent increase in oral oxycodone and heroin preference and intake under limited-access procedures and all, but 129S1/SvlmJ mice, exhibited oxycodone reinforcement. Relative to the other substrains, 129P3/J mice exhibited higher heroin and oxycodone intake. While 129X1/SvJ exhibited the highest anxiety-like behavior during natural opioid withdrawal, somatic and behavior signs of precipitated withdrawal were most robust in 129P3/J mice. These results demonstrate the feasibility and relative sensitivity of our oral opioid self-administration procedures for detecting substrain differences in drug reinforcement/intake among 129 mice, of relevance to the identification of genetic variants contributing to high vs. low oxycodone reinforcement and intake.

DOI10.1111/gbb.12393
Alternate JournalGenes Brain Behav.
PubMed ID28523735